quinazolines has been researched along with Kidney Diseases in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (40.00) | 18.7374 |
| 1990's | 4 (13.33) | 18.2507 |
| 2000's | 5 (16.67) | 29.6817 |
| 2010's | 7 (23.33) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chambers, C; Giani, J; Sawyer, MB | 1 |
| Jaźwiec, B; Kuliszkiewicz-Janus, M; Kwiatkowski, J; Małecki, R; Rymer, W | 1 |
| Hao, Z; Liang, C; Sun, Y; Wang, C; Zhang, L; Zhou, J | 1 |
| Emser, A; Gong, Y; von Eynatten, M; Woerle, HJ | 1 |
| Bossart, W; Etter, A; Fehr, T; Hässig, A; Müller, N; Roos, M; Schiesser, M; Wüthrich, RP | 1 |
| Li, JJ; Li, ZW; Mao, XQ; Shi, GF; Wang, F; Wang, L; Wang, Q; Wu, JJ; Zhang, JP; Zou, J | 1 |
| Bao, W; Cheng, SB; Chin, YE; Liu, N; Qiu, A; Shi, Y; Wang, L; Xiong, C; Xu, L; Yan, H; Yang, T; Zhuang, S | 1 |
| Chadjichristos, C; Chatziantoniou, C; Dussaule, JC; Flamant, M; François, H; Guerrot, D; Helle, F; Jouzel, C; Placier, S | 1 |
| Langmuir, P; Martin, P; Molz, KH; Oliver, S; Read, J; Smith, R; Weil, A | 1 |
| Eguchi, S; Fujigaki, Y; Hishida, A; Suzuki, H; Yamamoto, T | 1 |
| Bonneterre, J; Culine, S; de Jonge, MJ; de Vries, EG; Droz, J; Glimelius, B; Smith, R; Van Groeningen, C; Verweij, J; Young, J | 1 |
| Blum, RA; Marbury, TC; Pinquier, JL; Rauch, C | 1 |
| DATEY, KK; PANDYA, VN | 1 |
| Chansel, D; Chatziantoniou, C; Dussaule, JC; Flamant, M; François, H; Placier, S; Tharaux, PL | 1 |
| Edelman, MJ; Hohl, RJ; Hollis, DR; Kindler, HL; Lewis, LD; Lichtman, SM; Marshall, JL; Miller, AA; Murry, DJ; Owzar, K; Ratain, MJ; Villalona-Calero, MA | 1 |
| Delmez, JA; Harter, HR | 1 |
| Garcez, DM; Kopstein, J | 1 |
| Arnold, S; Baughman, RA; Benet, LZ; Chatterjee, K; Lin, ET; Williams, RL | 1 |
| Gotoh, E; Ishii, M; Minamisawa, K; Minamisawa, M; Shionoiri, H; Sugimoto, K; Takasaki, I; Takizawa, T; Ueda, S | 1 |
| Chmurzyńska, W; Grzelakowska-Sztabert, B; Manteuffel-Cymborowska, M | 2 |
| Avery, GS; Brogden, RN; Heel, RC; Speight, TM | 1 |
| Bailey, RR; Little, PJ; Lynn, KL; Neale, TL | 1 |
| Bensted, JP; Calvert, AH; Clinton, S; Hughes, LR; Jodrell, DI; Morgan, SE; Newell, DR | 1 |
| Bishop, JA; Calvert, AH; Grzelakowska-Sztabert, B; Gumbrell, LA; Harland, SJ; Harrap, KR; Jackman, AL; Judson, IR; Newell, DR; Sikora, E | 1 |
| Alison, DL; Calvert, AH; Harland, SJ; Jackman, AL; Jones, TR; McElwain, TJ; Newell, DR; Robinson, BA; Siddik, ZH; Wiltshaw, E | 1 |
| Lowenthal, DT; Shear, L | 1 |
| Craswell, PW; Ezzat, E; Kopstein, J; Moorhead, JF; Varghese, Z | 1 |
| Carmody, M; Keogh, B; Malone, D; O'Dwyer, WF | 1 |
2 review(s) available for quinazolines and Kidney Diseases
| Article | Year |
|---|---|
Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials.
Topics: Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Kidney Diseases; Linagliptin; Purines; Quinazolines; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome | 2013 |
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.
Topics: Animals; Benzothiadiazines; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Eruptions; Drug Therapy, Combination; Heart Rate; Humans; Hydralazine; Hypertension; Kidney; Kidney Diseases; Kinetics; Methyldopa; Prazosin; Quinazolines; Renin; Sodium Chloride Symporter Inhibitors; Time Factors | 1977 |
5 trial(s) available for quinazolines and Kidney Diseases
| Article | Year |
|---|---|
Effects of impaired renal function on the pharmacokinetics and toxicity of i.v. ZD9331, a novel non-polyglutamated thymidylate synthase inhibitor, in adult patients with solid tumors.
Topics: Adult; Aged; Antineoplastic Agents; Blood Cell Count; Creatinine; Enzyme Inhibitors; Female; Hematologic Diseases; Humans; Injections, Intravenous; Kidney Diseases; Male; Middle Aged; Neoplasms; Quinazolines; Thymidylate Synthase | 2002 |
Pharmacokinetics and safety of a single oral dose of once-daily alfuzosin, 10 mg, in male subjects with mild to severe renal impairment.
Topics: Administration, Oral; Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Area Under Curve; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Humans; Infusions, Intravenous; Injections, Subcutaneous; Kidney; Kidney Diseases; Male; Middle Aged; Quinazolines; Receptors, Adrenergic, alpha-1; Time Factors | 2002 |
Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101.
Topics: Administration, Oral; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Erlotinib Hydrochloride; Female; Follow-Up Studies; Humans; Kidney Diseases; Kidney Function Tests; Liver Diseases; Liver Function Tests; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neoplasms; Probability; Quinazolines; Risk Assessment; Survival Analysis; Treatment Outcome | 2007 |
Pharmacokinetics and pharmacodynamics of the alpha 1-adrenergic antagonist bunazosin retard in hypertensives.
Topics: Adrenergic alpha-1 Receptor Antagonists; Blood Pressure; Delayed-Action Preparations; Female; Half-Life; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Pulse; Quinazolines | 1994 |
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.
Topics: Animals; Benzothiadiazines; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Eruptions; Drug Therapy, Combination; Heart Rate; Humans; Hydralazine; Hypertension; Kidney; Kidney Diseases; Kinetics; Methyldopa; Prazosin; Quinazolines; Renin; Sodium Chloride Symporter Inhibitors; Time Factors | 1977 |
24 other study(ies) available for quinazolines and Kidney Diseases
| Article | Year |
|---|---|
Tolerability of pemetrexed and oxaliplatin in the treatment of stage III colon cancer during raltitrexed shortage.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Canada; Colonic Neoplasms; Female; Humans; Kidney Diseases; Middle Aged; Oxaliplatin; Pemetrexed; Quinazolines; Thiophenes; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Treatment of Essential Thrombocythemia with Anagrelide Is Associated with an Increased Risk of Worsened Kidney Function.
Topics: Aged; Calreticulin; Creatinine; Disease Progression; Female; Humans; Hydroxyurea; Janus Kinase 2; Kidney Diseases; Male; Middle Aged; Mutation; Platelet Aggregation Inhibitors; Quinazolines; Retrospective Studies; Risk Factors; Thrombocythemia, Essential; Treatment Outcome | 2021 |
Rutaecarpine alleviates renal ischemia reperfusion injury in rats by suppressing the JNK/p38 MAPK signaling pathway and interfering with the oxidative stress response.
Topics: Animals; Biomarkers; Biopsy; Blood Urea Nitrogen; Cytokines; Disease Models, Animal; Indole Alkaloids; Inflammation Mediators; Kidney Diseases; Kidney Function Tests; Male; MAP Kinase Signaling System; Oxidative Stress; Phosphorylation; Protective Agents; Quinazolines; Rats; Reactive Oxygen Species; Reperfusion Injury; Superoxide Dismutase | 2017 |
Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.
Topics: Adult; Aged; Allografts; Antibodies, Monoclonal; Azathioprine; Basiliximab; BK Virus; Cohort Studies; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Polyomavirus Infections; Proteinuria; Pyrroles; Quinazolines; Recombinant Fusion Proteins; Tacrolimus; Tumor Virus Infections; Viremia | 2014 |
Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury.
Topics: Animals; Animals, Newborn; Astrocytes; Cells, Cultured; Disease Models, Animal; ErbB Receptors; Exploratory Behavior; Female; Glial Fibrillary Acidic Protein; Gliosis; Kidney Diseases; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Recovery of Function; Regeneration; Spinal Cord Injuries | 2014 |
EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.
Topics: Animals; Chemokines; Cytokines; Disease Progression; ErbB Receptors; Fibroblasts; Fibrosis; Gefitinib; Hyperuricemia; Inflammation; Kidney; Kidney Diseases; Male; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Risk Factors; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1; Uric Acid | 2015 |
Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.
Topics: Animals; Arterioles; Blood Pressure; Chronic Disease; Disease Models, Animal; Enzyme Inhibitors; ErbB Receptors; Gefitinib; Hypertension; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Quinazolines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasoconstriction | 2009 |
Pharmacokinetics of vandetanib in subjects with renal or hepatic impairment.
Topics: Adult; Aged; Angiogenesis Inhibitors; Area Under Curve; Female; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Piperidines; Quinazolines | 2010 |
Comparison of ROCK and EGFR activation pathways in the progression of glomerular injuries in AngII-infused rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Disease Progression; ErbB Receptors; Gefitinib; Kidney Diseases; Kidney Glomerulus; Male; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Wistar; rho-Associated Kinases; Signal Transduction | 2011 |
QUINETHAZONE AS A DIURETIC AGENT.
Topics: Blood Protein Disorders; Diuretics; Heart Failure; Humans; Kidney Diseases; Liver Cirrhosis; Quinazolines; Sulfonamides | 1963 |
Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.
Topics: Animals; Capillaries; Collagen; Collagen Type I; Creatinine; Endothelin-1; ErbB Receptors; Fibrosis; Gefitinib; Gene Expression Regulation; Genes, Reporter; Glomerulosclerosis, Focal Segmental; Hypertension; Ischemia; Kidney; Kidney Cortex; Kidney Diseases; Kidney Glomerulus; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphorylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Proteinuria; Quinazolines; Rats; Rats, Sprague-Dawley | 2004 |
[Effects of prazosin on the control of arterial pressure in hypertensive patients subjected to dialysis].
Topics: Blood Volume; Female; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Prazosin; Quinazolines; Racial Groups; Renal Dialysis; Renin | 1980 |
[Prazosin in the treatment of arterial hypertension].
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Posture; Prazosin; Quinazolines | 1980 |
Altered prazosin pharmacokinetics in congestive heart failure.
Topics: Adult; Aged; Female; Heart Failure; Humans; Kidney Diseases; Kinetics; Liver; Male; Metabolic Clearance Rate; Middle Aged; Prazosin; Quinazolines | 1980 |
Polyamines in testosterone-induced hypertrophic and antifolate-induced hyperplastic mouse kidney. Differential effect of alpha-difluoromethylornithine.
Topics: Animals; Eflornithine; Female; Folic Acid; Hyperplasia; Hypertrophy; Kidney; Kidney Diseases; Mice; Organ Size; Ornithine Decarboxylase Inhibitors; Polyamines; Quinazolines; Testosterone | 1993 |
Prazosin in the treatment of patients with hypertension and renal functional impairment.
Topics: Female; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Prazosin; Quinazolines | 1976 |
Ornithine decarboxylase induction in mouse kidney as indicator of renal damage. Differential nephrotoxic effect of anticancer antifolate drugs.
Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers; Enzyme Induction; Female; Folic Acid; Folic Acid Antagonists; Indomethacin; Kidney; Kidney Diseases; Methotrexate; Mice; Organ Size; Ornithine Decarboxylase; Quinazolines | 1991 |
The renal effects of N10-propargyl-5,8-dideazafolic acid (CB3717) and a non-nephrotoxic analogue ICI D1694, in mice.
Topics: Animals; Carbon Radioisotopes; Cisplatin; Creatinine; Female; Folic Acid; Glomerular Filtration Rate; Inulin; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Quinazolines; Thiophenes; Thymidylate Synthase; Urea | 1991 |
Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717).
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Diuresis; Drug Evaluation; Folic Acid; Folic Acid Antagonists; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Middle Aged; Quinazolines; Thymidylate Synthase | 1987 |
A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717.
Topics: Acetylglucosaminidase; Acid Phosphatase; Alanine Transaminase; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Folic Acid; Folic Acid Antagonists; Glomerular Filtration Rate; Hematologic Diseases; Hyperbilirubinemia; Kidney Diseases; Leucyl Aminopeptidase; Neoplasms; Quinazolines; Skin Diseases; Thymidylate Synthase | 1986 |
New drugs--No. 12. Metolazone (zaroxolyn).
Topics: Antihypertensive Agents; Diuretics; Dose-Response Relationship, Drug; Drug Evaluation; Edema; Heart Failure; Hypertension; Kidney Diseases; Quinazolines; Sulfonamides | 1972 |
Use of a new diuretic agent (metolazone) in patients with edema and ascites.
Topics: Ascites; Blood Urea Nitrogen; Creatinine; Diuretics; Edema; Furosemide; Humans; Injections, Intravenous; Kidney Diseases; Liver Cirrhosis; Natriuresis; Potassium; Protein Binding; Quinazolines; Sodium; Sulfonamides; Time Factors; Urea | 1973 |
Use of metolazone, a new diuretic, in patients with renal disease.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Blood Glucose; Blood Pressure; Creatinine; Diuretics; Edema; Female; Glomerular Filtration Rate; Humans; Hypertension; Injections, Intravenous; Inulin; Kidney Diseases; Liver Function Tests; Male; Middle Aged; Potassium; Quinazolines; Renin; Sodium; Sulfonamides; Uric Acid | 1974 |
Clinical and biochemical evaluation of a new diuretic agent (Metolazone).
Topics: Adolescent; Adult; Aged; Diuretics; Female; Heart Failure; Humans; Hypertension; Ketones; Kidney Diseases; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Pulmonary Heart Disease; Quinazolines; Sulfonamides | 1971 |